Genetic Variants of Folate and Methionine Metabolism and PCNSL Incidence in a German Patient Population

Overview

Journal J Neurooncol

Publisher Springer

Date 2010 Mar 19

PMID 20237949

Citations 11

Authors

Delia Kurzwelly

Stefan Knop

Markus Guenther

Juergen Loeffler

Agnieszka Korfel

Eckhard Thiel

Holger Hebart

Matthias Simon

Michael Weller

Michael Linnebank

Ulrich Herrlinger

Affiliations

Soon will be listed here.

Abstract

Functional genetic polymorphisms involved in folate and methionine metabolism play an important role in both DNA synthesis and methylation, and affect the risk of various malignancies including lymphoproliferative disorders such as systemic non-Hodgkin's lymphoma. In a retrospective analysis of 185 immunocompetent patients with primary central nervous system lymphoma (PCNSL) and 212 population controls we therefore investigated eight genetic polymorphisms affecting methionine metabolism for potential association with the development of PCNSL. We observed underrepresentation of the G-allele of the methyltetrahydrofolate homocysteine S-methyltransferase (MTR) c.2756A > G (D919G) missense polymorphism among PCNSL patients (P = 0.045; odds ratio (OR) = 0.65; 0.43-0.99). Furthermore, for the methylenetetrahydrofolate reductase (MTHFR) c.1298A > C (E429A) polymorphism the mutated C-allele was found more frequently among PCNSL patients than among population controls (P = 0.026; OR = 1.57; 1.05-2.34). There were no associations of the other polymorphisms investigated (MTHFR c.677C > T, transcobalamin 2 (Tc2) c.776C > G, cystathionin beta-synthase (CBS) c.844_855ins68, reduced folate carrier-1 (RFC-1) c.80G > A, thymidylate synthase (TYMS) 28-bp repeat, and dihydrofolate reductase (DHFR) c.594 + 59del19 bp) and the presence of PCNSL. This analysis is the largest to date to evaluate associations between genetic variants of folate and methionine metabolism and PCNSL. Our results suggest the hypothesis that folate and methionine metabolism is relevant to susceptibility to PCNSL.

Citing Articles

Association of gene polymorphisms with non-Hodgkin lymphoma risk: Evidence from 31 articles.

Wang G, Wu Y, Jing Z, Wen R, Song Y, Feng Y J Cancer. 2024; 15(16):5277-5287.

PMID: 39247589 PMC: 11375544. DOI: 10.7150/jca.99351.

Targeting Homocysteine and Hydrogen Sulfide Balance as Future Therapeutics in Cancer Treatment.

Majumder A Antioxidants (Basel). 2023; 12(8).

PMID: 37627515 PMC: 10451792. DOI: 10.3390/antiox12081520.

Folate metabolizing gene polymorphisms and genetic vulnerability to preterm birth in Korean women.

Kwon B, Lee N, Kim H, Kang Y, Kim J, Park J Genes Genomics. 2021; 43(8):937-945.

PMID: 34027569 DOI: 10.1007/s13258-021-01082-3.

C677T and A1298C Polymorphisms in Breast Cancer, Gliomas and Gastric Cancer: A Review.

Petrone I, Bernardo P, Dos Santos E, Abdelhay E Genes (Basel). 2021; 12(4).

PMID: 33920562 PMC: 8073588. DOI: 10.3390/genes12040587.

The Frequency of the 677C>T and 1298A>C Polymorphisms in the Methylenetetrahydrofolate Reductase (MTHFR) Gene in the Population.

Nefic H, Mackic-Djurovic M, Eminovic I Med Arch. 2018; 72(3):164-169.

PMID: 30061759 PMC: 6021155. DOI: 10.5455/medarh.2018.72.164-169.

References

Sharp L, Little J . Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. 2004; 159(5):423-43. DOI: 10.1093/aje/kwh066. View

Ma J, Stampfer M, Christensen B, Giovannucci E, Hunter D, Chen J . A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 1999; 8(9):825-9. View

Johnson W, Stenroos E, Spychala J, Chatkupt S, Ming S, Buyske S . New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy?. Am J Med Genet A. 2004; 124A(4):339-45. DOI: 10.1002/ajmg.a.20505. View

Linnebank M, Homberger A, Junker R, Harms E, Koch H . High prevalence of the I278T mutation of the human cystathionine beta-synthase detected by a novel screening application. Thromb Haemost. 2001; 85(6):986-8. View

Weber T, Weber R, Kaulich K, Actor B, Lampel S, Buschges R . Characteristic chromosomal imbalances in primary central nervous system lymphomas of the diffuse large B-cell type. Brain Pathol. 2000; 10(1):73-84. PMC: 8098171. DOI: 10.1111/j.1750-3639.2000.tb00244.x. View

Kurzwelly D, Muller C, Korfel A, Thiel E, Linnebank M, Weller M . Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients. J Neurooncol. 2008; 90(1):53-5. DOI: 10.1007/s11060-008-9630-5. View

van der Put N, Gabreels F, STEVENS E, Smeitink J, Trijbels F, Eskes T . A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet. 1998; 62(5):1044-51. PMC: 1377082. DOI: 10.1086/301825. View

Henao O, Piyathilake C, Waterbor J, Funkhouser E, Johanning G, Heimburger D . Women with polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MS) are less likely to have cervical intraepithelial neoplasia (CIN) 2 or 3. Int J Cancer. 2004; 113(6):991-7. DOI: 10.1002/ijc.20695. View

Linnebank M, Schmidt S, Kolsch H, Linnebank A, Heun R, Schmidt-Wolf I . The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. Br J Cancer. 2004; 90(10):1969-71. PMC: 2409477. DOI: 10.1038/sj.bjc.6601777. View

10.

Lincz L, Scorgie F, Kerridge I, Potts R, Spencer A, Enno A . Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma. Br J Haematol. 2003; 120(6):1051-4. DOI: 10.1046/j.1365-2141.2003.04220.x. View

11.

Linnebank M, Moskau S, Farmand S, Fliessbach K, Kolsch H, Bos M . Homocysteine and carotid intima-media thickness in a german population: lack of clinical relevance. Stroke. 2006; 37(11):2840-2. DOI: 10.1161/01.STR.0000244764.02851.d3. View

12.

Semmler A, Simon M, Moskau S, Linnebank M . Polymorphisms of methionine metabolism and susceptibility to meningioma formation: laboratory investigation. J Neurosurg. 2008; 108(5):999-1004. DOI: 10.3171/JNS/2008/108/5/0999. View

13.

Linnebank M, Homberger A, Nowak-Gottl U, Marquardt T, Harms E, Koch H . Linkage disequilibrium of the common mutations 677C > T and 1298A > C of the human methylenetetrahydrofolate reductase gene as proven by the novel polymorphisms 129C > T, 1068C > T. Eur J Pediatr. 2000; 159(6):472-3. DOI: 10.1007/s004310051311. View

14.

Wiemels J, Smith R, Taylor G, Eden O, Alexander F, Greaves M . Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A. 2001; 98(7):4004-9. PMC: 31169. DOI: 10.1073/pnas.061408298. View

15.

Frosst P, Blom H, Milos R, Goyette P, Sheppard C, Matthews R . A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10(1):111-3. DOI: 10.1038/ng0595-111. View

16.

Montesinos-Rongen M, Kuppers R, Schluter D, Spieker T, Van Roost D, Schaller C . Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol. 1999; 155(6):2077-86. PMC: 1866926. DOI: 10.1016/S0002-9440(10)65526-5. View

17.

Winkelmayer W, Eberle C, Sunder-Plassmann G, Fodinger M . Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int. 2003; 63(6):2280-5. DOI: 10.1046/j.1523-1755.2003.00025.x. View

18.

Linnebank M, Fliessbach K, Kolsch H, Rietschel M, Wullner U . The methionine synthase polymorphism c.2756Aright curved arrow G (D919G) is relevant for disease-free longevity. Int J Mol Med. 2005; 16(4):759-61. View

19.

Harmon D, Shields D, Woodside J, McMaster D, Yarnell J, Young I . Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol. 1999; 17(4):298-309. DOI: 10.1002/(SICI)1098-2272(199911)17:4<298::AID-GEPI5>3.0.CO;2-V. View

20.

Moskau S, Golla A, Grothe C, Boes M, Pohl C, Klockgether T . Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families. Stroke. 2004; 36(1):5-8. DOI: 10.1161/01.STR.0000149936.33498.83. View